LianBio Development Agreements
2 Contracts & Agreements
- Commercialization Agreement, dated as of December 16, 2022, by and among LianBio Development (HK) Limited, LianBio Respiratory Limited, ReViral Ltd. and Pfizer Inc (Filed With SEC on March 28, 2023)
- Assignment and Assumption Agreement related to Pfizer Agreement, dated December 15, 2021, by and among LianBio and LianBio Development (HK) Limited (Filed With SEC on March 31, 2022)